Items of recent pandemic news you may have missed: Too much testing of asymptomatic immune people? The new risk calculus of the delta variant, the coming mitigations, the anatomy of why delta spreads so fast, and more. Plus a frippery. … Continue reading →
Nine items of recent pandemic news you may have missed: Rapid testing, mixing and matching vaccines, booster shots, the genetics predicting severe Covid-19, another blow to J&J, some mechanisms behind neurological damage, and more. Plus a frippery. 1. Pfizer wants … Continue reading →
Three items of recent pandemic news: Human trials near for an inhalable antiviral; rumors of bad behavior by Google with an infection-tracking and notification app; and the WHO recommends against vaccinating children. Plus a news brief and a frippery. WHO … Continue reading →
Two items of recent pandemic news: Studies point to long-lasting, possibly lifelong immunity from natural infection; and rapid developments in the highly political question of where SARS-CoV-2 came from. Plus news briefs and a pair of fripperies. Origin, again It … Continue reading →
Three items of recent pandemic news: Pfizer’s vaccine can keep for 30 days at refrigerator temperatures; neutralizing antibody levels emerge as a correlate of protection; and the long stretch of post-trauma grief that awaits us. Plus news briefs and a … Continue reading →
Two items of recent pandemic news: Sanofi & GSK get some good news from a Phase II study of their reformulated vaccine candidate; and questions swirl anew around the origins of the pandemic virus. Plus news briefs and a frippery. … Continue reading →
Three items of pandemic news you may have missed recently: A tapeworm remedy to fight Covid; you can stop sanitizing now; and a new concern about blood clots with the Johnson & Johnson vaccine. Plus news briefs and a frippery. … Continue reading →
Three items of pandemic news you may have missed recently: Moderna can pack more doses per vial; Emergent’s big mistake; and news on vaccines for kids as young as 12. Plus news briefs and a pair of fripperies. Pfizer is … Continue reading →
Herewith three items of pandemic news you may have missed: Vitamin D levels vs. infection probability in Black people; variant viruses infecting animals; and the roller coaster that is AstraZeneca’s Phase III results announcement. Plus news briefs and a frippery. … Continue reading →
Herewith three items of pandemic news you may have missed recently: Evidence that post-infection people could need only one shot; asymptomatics and long Covid; and AstraZeneca on pause across Europe over safety concerns. Plus news briefs and a frippery. AstraZeneca … Continue reading →
Herewith three items of pandemic news you may have missed recently: One instance in Oregon of a scary variant; quantifying the variants’ immune escape; and the new CDC guidelines. Plus news briefs and a frippery. A year Before we dive … Continue reading →
Herewith a couple of items of pandemic news you may have missed: Who is helping whom with manufacturing? And the impact of US export bans in support of Pfizer on vaccine production elsewhere. Plus news briefs and a frippery. US … Continue reading →
Would the course of Covid-19 in this country have been different if Medicare had covered routine dental exams and cleanings? Possibly. But the studies have not been done that could tell us with confidence, and they probably won’t be. Determining … Continue reading →
Three items of pandemic news you may have missed recently: FDA signals a streamlined approval path for vaccine updates; South Africa halts AstraZeneca distribution; and Moderna demonstrates its shot’s efficacy against viral variants. Plus news briefs and a frippery. Moderna’s … Continue reading →
Herewith three items of pandemic news you may have missed recently: A trial of mixed shots begins in the UK; a sobering tale of a variant’s spread; and J&J applies for an EUA. Plus news briefs and a frippery. Johnson … Continue reading →
